Cinemark Holdings, Inc. (CNK)
USD 30.92
(-2.03%)
USD 30.92
(-2.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 444.3 Million | 136 Million | 166.21 Million | -330.09 Million | 561.99 Million | 556.91 Million |
| Net Income | 184.9 Million | -268 Million | -422.21 Million | -617.94 Million | 193.84 Million | 215.3 Million |
| Depreciation & Amortization | 209.5 Million | 238.2 Million | 265.36 Million | 259.77 Million | 261.15 Million | 261.16 Million |
| Deferred income taxes | 10.6 Million | -9.3 Million | -22.63 Million | -38.9 Million | -1.84 Million | 23.18 Million |
| Stock-based compensation | 25 Million | 21.5 Million | 29.3 Million | 19.4 Million | 14.61 Million | 14.33 Million |
| Change in working capital | 22.1 Million | -25.2 Million | 252.87 Million | -158.16 Million | 26.42 Million | -5.96 Million |
| Other non-cash items | -7.8 Million | 178.8 Million | 63.55 Million | 205.73 Million | 67.79 Million | 48.89 Million |
| Investing Cash Flow | -131.8 Million | -96.3 Million | -89.29 Million | -83.36 Million | -310.64 Million | -451.37 Million |
| Investments in PPE | -149.5 Million | -110.7 Million | -95.54 Million | -83.93 Million | -303.62 Million | -346.07 Million |
| Acquisitions | 17.7 Million | 14.4 Million | 6.24 Million | -50 Thousand | -10.17 Million | -109.21 Million |
| Investment purchases | - | - | - | -50 Thousand | - | -97.92 Million |
| Sales/Maturities of investments | - | - | - | 50 Thousand | - | - |
| Other Investing Activities | 2.9 Million | 14.4 Million | 6.2 Million | 614 Thousand | 3.15 Million | 3.92 Million |
| Financing Cash Flow | -125.4 Million | -52.2 Million | -19.93 Million | 584.4 Million | -186.5 Million | -192.64 Million |
| Debt repayment | -122 Million | -42.4 Million | -1.17 Billion | -22.12 Million | -22.58 Million | -33.33 Million |
| Dividends payments | - | - | - | -42.31 Million | -159.28 Million | -149.49 Million |
| Common Stock Repurchased | -2.9 Million | -4.3 Million | -4.1 Million | -5.4 Million | -2.3 Million | -2.9 Million |
| Common Stock Issuance | - | - | - | 89.42 Million | 2.3 Million | - |
| Other Financing Activities | -3.4 Million | -5.5 Million | 1.16 Billion | 564.81 Million | -4.64 Million | -9.81 Million |
| Accounts receivables | -23.6 Million | -1.2 Million | -43.57 Million | 58.45 Million | 11.32 Million | -4.58 Million |
| Accounts payables | 45.4 Million | -25.1 Million | 175.5 Million | -97.27 Million | 36.1 Million | -11.4 Million |
| Inventory | 300 Thousand | -8.2 Million | -2.85 Million | 9.09 Million | -2.36 Million | -1.81 Million |
| Other working capital | 300 Thousand | 9.3 Million | 123.8 Million | -128.44 Million | -18.63 Million | 11.83 Million |
| Cash at beginning of period | 674.5 Million | 707.3 Million | 655.33 Million | 488.31 Million | 426.22 Million | 522.54 Million |
| Cash at end of period | 849.1 Million | 674.5 Million | 707.33 Million | 655.33 Million | 488.31 Million | 426.22 Million |
| Capital Expenditure | -149.5 Million | -110.7 Million | -95.54 Million | -83.93 Million | -303.62 Million | -346.07 Million |
| Effect of forex changes on cash | -12.5 Million | -20.3 Million | -4.99 Million | -3.91 Million | -2.75 Million | -9.22 Million |
| Net cash flow / Change in cash | 174.6 Million | -32.8 Million | 52 Million | 167.02 Million | 62.09 Million | -96.32 Million |
| Free Cash Flow | 294.8 Million | 25.3 Million | 70.67 Million | -414.02 Million | 258.36 Million | 210.84 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 191.5 Million | 44.9 Million | 24.4 Million | 184.9 Million | -17.7 Million | 81.3 Million |
| Depreciation & Amortization | 49.1 Million | 49.8 Million | 49.4 Million | 209.5 Million | 49.9 Million | 51.9 Million |
| Deferred income taxes | -57.4 Million | -9.6 Million | -37.1 Million | 10.6 Million | -5.4 Million | 11.7 Million |
| Stock-based compensation | 8.4 Million | 9.3 Million | 6.4 Million | 25 Million | 6.1 Million | 7 Million |
| Change in working capital | -36.9 Million | 89.4 Million | -52.5 Million | 22.1 Million | 74.6 Million | -58.8 Million |
| Other non-cash items | -47.3 Million | 110 Million | 91.9 Million | -7.8 Million | 1 Million | -13.3 Million |
| Investing Cash Flow | -42.7 Million | -23.1 Million | -23.3 Million | -131.8 Million | -56.9 Million | -20.3 Million |
| Investments in PPE | -43 Million | -23.7 Million | -23.5 Million | -149.5 Million | -59.8 Million | -35.1 Million |
| Acquisitions | -200 Thousand | - | 200 Thousand | 17.7 Million | 2.9 Million | 14.8 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 500 Thousand | 600 Thousand | 200 Thousand | 2.9 Million | 2.9 Million | 14.8 Million |
| Financing Cash Flow | 73.4 Million | -157.7 Million | -10.4 Million | -125.4 Million | -7.4 Million | -7.2 Million |
| Debt repayment | -150.3 Million | -156.1 Million | -5.6 Million | -122 Million | -5.7 Million | -3.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 4.4 Million | -200 Thousand | -4.2 Million | -2.9 Million | -400 Thousand | -100 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 219.3 Million | -800 Thousand | -4.8 Million | -3.4 Million | -1.7 Million | -3.9 Million |
| Accounts receivables | - | - | - | -23.6 Million | -11.5 Million | - |
| Accounts payables | - | - | - | 45.4 Million | 11.2 Million | - |
| Inventory | - | - | - | 300 Thousand | 300 Thousand | - |
| Other working capital | -36.9 Million | 89.4 Million | -52.5 Million | 300 Thousand | 74.6 Million | -58.8 Million |
| Cash at beginning of period | 788.8 Million | 788.6 Million | 849.1 Million | 674.5 Million | 805.9 Million | 515.7 Million |
| Cash at end of period | 928.3 Million | 788.8 Million | 788.6 Million | 849.1 Million | 849.1 Million | 805.9 Million |
| Capital Expenditure | -43 Million | -23.7 Million | -23.5 Million | -149.5 Million | -59.8 Million | -35.1 Million |
| Effect of forex changes on cash | 1.4 Million | -3.9 Million | -4.1 Million | -12.5 Million | -1 Million | -9.3 Million |
| Net cash flow / Change in cash | 139.5 Million | 200 Thousand | -60.5 Million | 174.6 Million | 43.2 Million | 290.2 Million |
| Free Cash Flow | 64.4 Million | 161.2 Million | -46.2 Million | 294.8 Million | 48.7 Million | 44.7 Million |
ACVA
TITANBIO
PML
LPSB
RHHVF
2605